These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26656880)

  • 1. Brain Biomarkers of Vulnerability and Progression to Psychosis.
    Cannon TD
    Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S127-32. PubMed ID: 26656880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of microRNA Expression in Cortical Development During Conversion to Psychosis.
    Zheutlin AB; Jeffries CD; Perkins DO; Chung Y; Chekroud AM; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Seidman LJ; Walker EF; Woods SW; Tsuang M; Cannon TD
    Neuropsychopharmacology; 2017 Oct; 42(11):2188-2195. PubMed ID: 28186095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Individualized Risk Calculator for Research in Prodromal Psychosis.
    Cannon TD; Yu C; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Heinssen R; Jeffries CD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Kattan MW
    Am J Psychiatry; 2016 Oct; 173(10):980-988. PubMed ID: 27363508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    Schizophr Res; 2019 Jun; 208():41-43. PubMed ID: 30745066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project.
    Carrión RE; Cornblatt BA; Burton CZ; Tso IF; Auther AM; Adelsheim S; Calkins R; Carter CS; Niendam T; Sale TG; Taylor SF; McFarlane WR
    Am J Psychiatry; 2016 Oct; 173(10):989-996. PubMed ID: 27363511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.
    Cannon TD; Chung Y; He G; Sun D; Jacobson A; van Erp TG; McEwen S; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Jeffries C; Seidman LJ; Tsuang M; Walker E; Woods SW; Heinssen R;
    Biol Psychiatry; 2015 Jan; 77(2):147-57. PubMed ID: 25034946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?
    Khoury R; Nasrallah HA
    Schizophr Res; 2018 Sep; 199():31-38. PubMed ID: 29703661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders.
    Chung Y; Jacobson A; He G; van Erp TG; McEwen S; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; Heinssen R; Cannon TD
    Mol Neuropsychiatry; 2015 May; 1(1):13-22. PubMed ID: 26005673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk.
    Cao H; McEwen SC; Chung Y; Chén OY; Bearden CE; Addington J; Goodyear B; Cadenhead KS; Mirzakhanian H; Cornblatt BA; Carrión RE; Mathalon DH; McGlashan TH; Perkins DO; Belger A; Seidman LJ; Thermenos H; Tsuang MT; van Erp TGM; Walker EF; Hamann S; Anticevic A; Woods SW; Cannon TD
    Schizophr Bull; 2019 Jun; 45(4):924-933. PubMed ID: 30215784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.
    Woodberry KA; Shapiro DI; Bryant C; Seidman LJ
    Harv Rev Psychiatry; 2016; 24(2):87-103. PubMed ID: 26954594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of functional outcome in individuals at high clinical risk for psychosis at six years follow-up.
    Brandizzi M; Valmaggia L; Byrne M; Jones C; Iwegbu N; Badger S; McGuire P; Fusar-Poli P
    J Psychiatr Res; 2015 Jun; 65():115-23. PubMed ID: 25837413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prodrome and clinical risk for psychotic disorders.
    Goulding SM; Holtzman CW; Trotman HD; Ryan AT; Macdonald AN; Shapiro DI; Brasfield JL; Walker EF
    Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):557-67. PubMed ID: 24012073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping prodromal psychosis: a critical review of neuroimaging studies.
    Fusar-Poli P; McGuire P; Borgwardt S
    Eur Psychiatry; 2012 Apr; 27(3):181-91. PubMed ID: 21940151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation and extension of the NAPLS-2 and SIPS-RC personalized risk calculators in an independent clinical high-risk sample.
    Osborne KJ; Mittal VA
    Psychiatry Res; 2019 Sep; 279():9-14. PubMed ID: 31279247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers.
    Koutsouleris N; Riecher-Rössler A; Meisenzahl EM; Smieskova R; Studerus E; Kambeitz-Ilankovic L; von Saldern S; Cabral C; Reiser M; Falkai P; Borgwardt S
    Schizophr Bull; 2015 Mar; 41(2):471-82. PubMed ID: 24914177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Brain imaging of first-episode psychosis].
    Jardri R
    Encephale; 2013 Sep; 39 Suppl 2():S93-8. PubMed ID: 24084428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive validity of conversion from the clinical high risk syndrome to frank psychosis.
    Yoviene Sykes LA; Ferrara M; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Mathalon DH; Seidman LJ; Tsuang MT; Walker EF; McGlashan TH; Woodberry KA; Powers AR; Ponce AN; Cahill JD; Pollard JM; Srihari VH; Woods SW
    Schizophr Res; 2020 Feb; 216():184-191. PubMed ID: 31864837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis.
    Worthington MA; Walker EF; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Cannon TD
    Schizophr Res; 2021 Jan; 227():95-100. PubMed ID: 33046334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis-like experiences and distress among adolescents using mental health services.
    Kline E; Thompson E; Bussell K; Pitts SC; Reeves G; Schiffman J
    Schizophr Res; 2014 Feb; 152(2-3):498-502. PubMed ID: 24411529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.